Condition
Alcohol Related Neurodevelopmental Disorder
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT01149538Phase 1Completed
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
NCT01994603Not ApplicableCompleted
Expansion to Interdisciplinary HIV Prevention in Women
NCT01971398Not ApplicableCompleted
Development of Education Materials for Prevention of FAS in Russia
Showing all 3 trials